VA
Therapeutic Areas
Bio Usawa Biotechnology Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Rituximab Biosimilar | Non‑Hodgkin Lymphoma | Preclinical |
| Trastuzumab Biosimilar | HER2‑Positive Breast Cancer | Preclinical |
| Bevacizumab Biosimilar | Various Solid Tumors | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Rituximab Biosimilar | Non‑Hodgkin Lymphoma | Preclinical |
| Trastuzumab Biosimilar | HER2‑Positive Breast Cancer | Preclinical |
| Bevacizumab Biosimilar | Various Solid Tumors | Preclinical |